Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.5B
136M shares
52-week range
$3.13 – $11.68
99% from low
Sector
SERVICES-HEALTH SERVICES
Exchange
NASDAQ
CS
Borrow rate
0.46%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $465.6M | $567.2M | $637.8M | $698.6M | $688.1M | $763.9M | $853.7M |
| Cost of revenue | $355.0M | $425.9M | $476.0M | $563.3M | $586.8M | $631.8M | $268.9M |
| Gross profit | $110.6M | $141.3M | $161.8M | $135.4M | $101.3M | $132.1M | $584.8M |
| Gross margin | 23.8% | 24.9% | 25.4% | 19.4% | 14.7% | 17.3% | 68.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $39.7M | $50.9M | $74.8M | −$4.4M | −$49.4M | −$23.2M | −$29.8M |
| EBITDA | $45.9M | $61.5M | −$5.9M | $9.2M | −$33.9M | $1.2M | $3.4M |
| Net income | $19.6M | $26.3M | −$44.0M | −$6.5M | −$40.7M | −$21.3M | −$30.3M |
| Net margin | 4.2% | 4.6% | -6.9% | -0.9% | -5.9% | -2.8% | -3.6% |
| EPS (diluted) | 0.15 | 0.20 | -0.33 | -0.05 | -0.30 | -0.16 | -0.22 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $966M | $0.11 | $-0.06–$0.39 | 2 |
| 2027 | $1.0B | $0.41 | $0.32–$0.53 | 2 |
| 2028 | $1.1B | $0.48 | $0.48–$0.49 | 1 |
Forward consensus · source: Financial Modeling Prep
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
www.innovage.comNo one on the platform currently holds INNV.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 370,817 | $3.0M |
| Execution date | Ratio |
|---|---|
| 2019-03-18 | 1-for-105reverse |
No one on the platform has traded INNV yet.
| $241M |
| — |
| CMPSCOMPASS Pathways plc | $15.07 | +1.69% | $1.4B | — |
| CYHCommunity Health Systems, Inc. | $3.39 | +3.35% | $478M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 1.9× sales vs its 1.0× historical median P/S.
Fair value ≈ $6.30 · price $11.61 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$INNV Signal Update Today's recommendation from our system is to STAY LONG. The previous BUY signal was issued on 06/05/2026, 21 days ago, when the stock price was 7.2600. Since then, INNV has risen by +48.62%.
View on StockTwits ↗$ASTH here’s math. 350mm 27 ebitda 14x ($INNV trades for this valuation; max health acquired by $HUM a few months ago for this valuation) 4.9bn -500mm net debt $4.4bn /55mm shares $80/sh target price This isn’t a stretch and this isn’t a meme stock. This is a real cash flowing biz with years of 15-20% growth runway.
View on StockTwits ↗$INNV for the move this is about to make no one here cc @zerodayrounder you take some?
View on StockTwits ↗$INNV might be a tad early here but if I'm not this will lockout
View on StockTwits ↗$INNV if you cam get these monthly setups that just run on a b/o usually my favorite
View on StockTwits ↗$INNV Q3 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.22 down -175.00% YoY • Reported revenue of $251.94M up 15.49% YoY • InnovAge is raising its fiscal 2026 guidance for total revenues to a range of $950M to $975M and Adjusted EBITDA to a range of $85 million to $90 million.
View on StockTwits ↗Imagine buying $INNV at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $INNV investors out there, we’ve got some important news for you: A $27 million recovery fund is officially open to shareholders who bought between March 4, 2021, and December 22, 2021. This recovery fund was established after claims that InnovAge misled investors about the quality of care and regulatory compliance at its healthcare centers following its IPO. Even though the official deadline has passed, the court is still accepting late submissions. Claim your share here: https://11th.com/cases/innovage-investor-settlement
View on StockTwits ↗$INNV Share Price: $8.09 Contract Selected: Nov 20, 2026 $10 Calls Buy Zone: $1.01 – $1.25 Target Zone: $1.68 – $2.06 Potential Upside: 57% ROI Time to Expiration: 206 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$INNV investors — there's no hidden secret here. Just one thing you really need to know. Here's how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/innovage-investor-settlement
View on StockTwits ↗$INNV investors, if you follow us, you already know about it. This info hits different after the news. Check it out: https://11th.com/cases/innovage-investor-settlement
View on StockTwits ↗$INNV I am up 64% on my stock. If you want to see more trades check my bio for the link to join for FREE. I been doing buying stock for last 20 years .
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.